Irvine-based Epinal Inc. has emerged from stealth mode after more than six years of development, introducing a semiconductor-based biosensor that can detect narcotics directly from human breath.
The technology is designed for use in disposable breathalyzer cartridges and can also detect substances in breath that may indicate the presence of certain diseases, allowing for rapid, noninvasive testing.
“People around the world lose loved ones every day to narcotics and various diseases, myself included,” Mark Wong, co-founder and chief executive of Epinal, said in a statement.
“We feel that with proactive screening and monitoring, countless lives can be saved with early detection and treatment.”
Epinal is targeting 2028 to begin production.
